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Chaperones that cure yeast artificial [PSI+] and their prion-
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Vitaly V. Kushnirov, Dmitry S. Kryndushkin, Magdalena Boguta*,
Vladimir N. Smirnov and Michael D. Ter-Avanesyan
The [PSI+] nonsense-suppressor determinant of
Saccharomyces cerevisiae results from the ability of
Sup35 (eRF3) translation termination factor to undergo
prion-like aggregation [1]. Although this process is
autocatalytic, in vivo it depends on the chaperone
Hsp104, whose lack or overexpression can cure [PSI+]
[2]. Overproduction of the chaperone protein Ssb1
increased the [PSI+] curing by excess Hsp104, although
it had no effect on its own, and excess chaperone
protein Ssa1 protected [PSI+] against Hsp104 [3,4]. We
used an artificial [PSI+PS] based on the Sup35 prion-
forming domain from yeast Pichia methanolica [5] to
find other prion-curing factors. Both [PSI+PS] and [PSI+]
have prion ‘strains’, differing in their suppressor
efficiency and mitotic stability. We show that [PSI+PS]
and a ‘weak’ strain of [PSI+] can be cured by
overexpression of chaperones Ssa1, Ssb1 and Ydj1. The
ability of different chaperones to cure [PSI+PS] showed
significant prion strain specificity, which could be
related to variation in Sup35 prion structure. Our results
imply that homologs of these chaperones may be active
against mammalian prion and amyloid diseases.
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Results and discussion
The genetic system for detection of [PSI+] phenotype in
the strains used here includes ade2-1 UAA nonsense muta-
tion and SUQ5 (SUP16) tRNA suppressor, which sup-
presses ade2-1 only in combination with [PSI+]. The [psi–]
cells are adenine requiring and accumulate red pigment
related to impaired adenine biosynthesis. [PSI+] cells are
adenine independent and form white (‘strong’ suppressor
[PSI+] strains) or pink (‘weak’ strains) colonies. The work
was inspired by the observation of different effects of
Hsp104 overproduction on [PSI+PS] and conventional
[PSI+]. In [PSI+] cells it caused antisuppression and gradual
[PSI+] loss. Both effects were manifest as red colony color
[1,2], which complicated the observation of [PSI+] elimi-
nation. In contrast, no antisuppression was observed in
[PSI+PS] cells overproducing Hsp104, allowing us to detect
[PSI+PS] loss by red sectors in white colonies. We were
interested to see if an increase in other chaperones
together with Hsp104 caused antisuppression in [PSI+PS]
cells. Chaperones functionally related to Hsp104 were
chosen: Ssa1, Ssb1 and Ydj1. Ssa1 and Ssb1 influenced
[PSI+] curing by Hsp104 [3,4]. In vitro, Hsp104, Ssa1 and
Ydj1 acted together to reactivate aggregated denatured
proteins [6]. Four Ssa and two Ssb proteins represent two
major families of yeast Hsp70 homologous to bacterial chap-
erone DnaK. Ydj1 corresponds to DnaJ, a co-chaperone for
DnaK. The ‘strong’ [PSI+PS] isolates 1 and 2 [5] were
transformed with the multicopy plasmid encoding Hsp104
or control vector and then with multicopy plasmids
encoding Ssa1, or Ssb1 or Ydj1, or Ssa1 and Ydj1 together.
The transformants were white or red/white sectored, sug-
gesting [PSI+PS] loss but no antisuppression. In addition,
[PSI+PS] curing did not significantly depend on Hsp104
overproduction and was mainly defined by overexpression
of Ssa1, Ssb1 and Ydj1. We therefore focused on the prion-
curing effects of these chaperones. 
Two prion strains used above plus ‘weak’ [PSI+PS] strains
3 and 4, and ‘strong’ and ‘weak’ conventional [PSI+], were
characterized for levels of nonsense suppression (Table 1).
Strains were transformed with multicopy plasmids encod-
ing Ssa1, Ssb1, Ydj1, Hsp104, or Ssa1 and Ydj1 simultane-
ously. Many transformants segregated red sectors (Figure 1)
which contained [psi–] cells, as confirmed by scoring the
[psi–] phenotype among the plasmid-less subclones of
transformants. The frequency of [PSI+PS] loss was approx-
imately equal to the extent of red sectors in transformants
(Table 1). The strong conventional [PSI+] was insensi-
tive to overexpression of the chaperones tested, excluding
Hsp104 which caused moderate antisuppression (light red
but Ade+ colonies) and occasional [PSI+] loss (data not
shown). Weak [PSI+] was efficiently cured by Hsp104 and
by Ssb1 and less efficiently by simultaneous overexpres-
sion of Ssa1 and Ydj1 (Figure 1). Thus, Ssa1, Ssb1 and
Ydj1 are novel prion-curing factors active against [PSI+PS]
and weak [PSI+].
In some cases, the overexpression of chaperones caused
growth inhibition. Transformants overproducing Ssb1 grew
at about half the normal rate, independent of their [PSI+PS]
or [PSI+] status, as estimated by the time required to reach
an average colony diameter of 0.5 mm. Overproduced Ssa1
and Hsp104 inhibited growth of only ‘strong’ [PSI+PS] 1
and 2 by about 1.5–2-fold. Inhibition by excess Ydj1 was
only noted in [PSI+PS] 2, whereas simultaneous overex-
pression of Ydj1 and Ssa1 in [PSI+PS] 2 caused heteroge-
neous growth, with the majority of colonies being
inhibited more than twofold. Thus, the inhibitory effects
of chaperones, except for Ssb1, correlated with high sup-
pression levels of the original strains.
It has been shown previously that [PSI+] strains have
increased tolerance to heat shock, which could reflect
increased levels of stress proteins as a result of trans-
lational readthrough [7]. We tested the levels of Ssa, Ssb,
Ydj1 and Hsp104 by western dot blotting in all studied
strains and their [psi–] variants. Antibodies to Ssa1 and
Ssb1 respectively recognized all four Ssa or both Ssb pro-
teins. No significant dependence on [PSI+] was found,
which agrees with the earlier data for Hsp104, Hsp70 and
Hsp26 [7]. The increase in the levels of chaperones as a
result of their multicopy expression varied greatly for dif-
ferent chaperones (Table 1). Similar data were obtained
for the transformants of [PSI+PS] 1 and [psi–] strains. Ssa was
increased only 1.5-fold, which agrees with the earlier data,
relating this to tight autoregulation of the Ssa protein
family [4,8]. A twofold increase in Ssb suggests a similar
mechanism for Ssb proteins, whereas the 30-fold increase
in Hsp104 indicates lack of autoregulation. Ydj1 showed
intermediate ninefold induction. The Ydj1 level was about
one half of normal in transformants overexpressing Ssa1
alone, and three times normal upon overexpression of
both Ydj1 and Ssa1. This represents a 67% reduction in
comparison with the ninefold increase in Ydj1 level upon
overexpression of Ydj1 only. The level of Hsp104 did not
significantly depend on overexpression of other chaper-
ones, except for Ssb1, which reduced Hsp104 to 70 ± 15%
of normal. This suggests that the effects of novel prion-
curing chaperones were independent of the known Hsp104
mechanism. In the case of Ssb1 overexpression, the
decrease of Hsp104 was also unlikely to cause the [PSI+]
loss, because, as we observed, the loss was not affected by
Hsp104 overproduction.
The efficiency of [PSI+PS] curing varied greatly depend-
ing on the [PSI+PS] strain and overexpressed chaperone
(Figure 1). However, the curing efficiency could not be
represented as an additive function of the ‘sensitivity’ of a
prion strain and the curing ‘potency’ of a chaperone. Situa-
tions were frequently observed when one chaperone was
more efficient than another in curing of one [PSI+PS]
strain, but was less efficient against another [PSI+PS] or
[PSI+] strain. The unique patterns of sensitivity of
[PSI+PS] strains to overexpressed chaperones may enable
us to distinguish prion strains with similar suppressor effi-
ciency. For example, of the two ‘strong’ [PSI+PS] strains,
[PSI+PS] 1 was sensitive to Ssa1 and Ydj1, but insensitive
to Ssb1, whereas [PSI+PS] 2 was sensitive to Ssb1 but almost
insensitive to Ssa1 and Ydj1. Two ‘weak’ [PSI+PS] strains
tested, 3 and 4, were also easily distinguishable, as
[PSI+PS] 3 was much more sensitive to all overproduced
chaperones except Hsp104.
The chaperones studied showed different specificity for
curing prion strains, the only exception being the Ssa1 Ydj1
pair. Furthermore, simultaneous overexpression of Ssa1
and Ydj1 cured [PSI+PS] much more efficiently than either
alone. This agrees with earlier findings that Ydj1 acts as an
Ssa1 partner, increasing its efficiency in vitro [9]. The
remarkably different curing specificities of chaperones can
hardly be explained by possible variation in their expres-
sion. More probably, they reflect the specificity of chaper-
one interactions with the prion strains. The sensitivity of
prion strains to chaperones is likely to depend on such
factors as the efficiency of prion recognition by chaperones
and the ability of prions to withstand a particular chaper-
one activity. Chaperones are believed to recognize exposed
hydrophobic fragments of misfolded proteins, which
should normally be buried inside protein molecules. The
amount of such fragments and, therefore, the recognition
efficiency should vary depending on the prion strain-spe-
cific folding. The primary structure of the prion domain
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Table 1
[PSI+PS] and [PSI+] curing by overproduced chaperones.
Overproduced chaperones
[PSI+PS], Suppressor Ssa1 Ydj1 Ssa1 + Ssb1 Hsp
[PSI+] efficiency (%) Ydj1 104
1 40.1 ± 5.4 ± + ++ – –
2 53.5 ± 12.6 – – +* + –
3 6.8 ± 0.4 ++ ++ +++ +++ ±
4 13.1 ± 2.3 – – + ++ +
Weak 7.65 ± 1.32 – – + ++ +++
Strong 27.98 ± 7.20 – – – – +
Chaperone 1.5 9 1.5 and 3 2 30
excess (fold)†
The efficiency of prion curing for the strains presented in Figure 1 and
for ‘strong’ [PSI+] was interpreted as follows: –, no curing; ±,
inefficient curing; +, noticeable curing; ++, efficient curing; +++,
(almost) complete curing. +*, the majority of these transformants were
strongly inhibited for growth and did not lose [PSI+PS], whereas larger
red-sectored colonies represented the minority. At least 100
transformants were studied for each combination of strain and
chaperone. Each transformation was repeated at least twice. †Increase
in levels of the indicated chaperones in the lysates of [PSI+PS] 1
transformants overexpressing these chaperones compared with the
control lysate, as determined by densitometry of western dot blots of
sequentially diluted lysates. The standard error did not exceed 20%.
The blots were developed using the ECL system (Amersham). The
strains were characterized for the level of UAA readthrough (an
average of three independent measurements) in the absence of excess
chaperones. The UAA readthrough for 5V-H19 [psi–] was 2.3 ± 0.5%
and for [psi–PS] was 2.8 ± 0.7%.
could also modulate the recognition efficiency. Kinetic
parameters such as prion polymerization speed should also
depend on folding and influence the resistance of prions to
chaperones. Therefore, a prion fold could define the sensi-
tivity of prions to chaperones in many ways.
The above considerations suggest an explanation for the
observation that [PSI+PS] is more resistant to Hsp104
overexpression than [PSI+]. We have proposed that Sup35
prion aggregates represent amyloid-like fibers, which are
fragmented by Hsp104 [10]. Higher Hsp104 levels result
in smaller fragments, and curing would occur when they
become too small to seed polymerization. Prion conver-
sion and polymerization should occur only at the ends of
fibers, so the overall conversion rate is a product of poly-
merization speed and number of fibers. Two [PSI+] strains
with similar suppressor efficiency should have similar
levels of soluble Sup35 and a similar prion conversion rate.
Given this, one strain may have a higher polymerization
speed, but fewer prion particles than the other. Appar-
ently, such a prion is recognized less well by Hsp104 and
should be more resistant to Hsp104 overproduction. The
properties of [PSI+PS] resemble this case. In addition to
higher Hsp104 resistance, their lower mitotic stability may
be related to the presence of fewer prion particles and
the Sup35PS prion particles appear to sediment faster
than that of Sup35 [5].
Ssb proteins are functionally distinct from Ssa despite
their 60% sequence similarity. It is not clear what causes
the different prion-curing properties of Ssa1 and Ssb1.
The model mentioned [10] suggests two routes for prion
curing: either to break prion particles, as proposed for
Hsp104, or to interfere with polymerization. The lack
of synergistic effects of overexpression of Hsp104 with
other chaperones suggests that their involvement is not
critical for the first route. More likely, they act through the
second route, by binding to the growth-competent sur-
faces of prion polymers or to imperfectly folded monomers
of prion protein. Ssa1 has been reported to inhibit [PSI+]
curing by excess Hsp104 [4]. In contrast, we observed that
overproduction of Ssa1 caused either prion curing or no
effects depending on the prion strain and origin of the
prion domain. Thus, the earlier data represent a particular
case of a more general situation that Ssa1 can exert oppo-
site effects on prion propagation, depending on the prion. 
Whereas the chaperones Ssa1, Ssb1 and Ydj1 were rela-
tively inefficient against [PSI+], they were clearly more
efficient than Hsp104 against [PSI+PS]. This suggests that
the prion-curing efficiency of chaperones depends on the
primary structure of the prion domain. This agrees with
the different Hsp104 effects on other prions: in contrast
to [PSI+], [PIN+] was insensitive to Hsp104 overexpres-
sion, and [URE3] was able to propagate in the absence of
Hsp104 [11,12]. Therefore, different sets of chaperones
may be active in curing different prions and, as we observed
here, even different strains of the same prion. We there-
fore suggest that the prion-curing potential of Ssa1, Ssb1
and Ydj1 is not restricted to [PSI+PS], but represents a
more general case.
The properties of yeast prions suggest that they are fun-
damentally similar not only to mammalian prions, but also
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Figure 1
[PSI+PS] and [PSI+] curing by chaperones.
Cells of the [PSI+PS] strains 1–4 and weak
[PSI+] were transformed with multicopy
plasmids carrying the indicated chaperone
genes and grown on selective media
containing a reduced amount of adenine
(6 mg/l) for better development of red colony
color. Photographs were taken after 6 days of
growth.









to amyloids. Like amyloidogenic proteins, Sup35 assem-
bled in vitro into uniform fibers which showed the key
properties of amyloids [13]. Both prions and amyloids use
an autocatalytic mechanism of conformational rearrange-
ment. Therefore, yeast prions may be a convenient model
for finding factors active against human prion and
amyloid diseases. The anti-prion effect of Ssa1, Ssb1 and
Ydj1 suggests that their human homologs could act as
such factors. Such homologs with high similarity levels of
74% (Ssa1), 61% (Ssb1) and 48% (Ydj1) are present in
humans. In contrast, no good homolog for Hsp104 has yet
been found in humans or in metazoa in general, including
the completely sequenced genomes of Caenorhabditis
elegans and Drosophila melanogaster (by BLAST search
at http://www.ncbi.nlm.nih.gov/BLAST/). The validity of
this approach was confirmed by recent data that the over-
expression of human Ydj1 homologs HDJ-1 and HDJ-2 in
mammalian cells suppressed the aggregation and toxicity
of ataxin-3 with expanded polyglutamine tract [14]. Over-
expression of HSP70 in Drosophila suppressed neuro-
degeneration associated with expanded ataxin-3, although
it did not prevent its aggregation [15]. A more systematic
search may reveal additional factors that influence prion
propagation in yeast and could be used as tools for treat-
ment of human amyloidoses.
Materials and methods
The yeast strains used were 5V-H19 a ade2-1 SUQ5 ura3-52 leu2-
3,112 can1-100 [PSI+] and its derivative PS-5V-H19 [PSI+PS], which
expresses hybrid Sup35 with a prion domain from P. methanolica as a
result of an altered chromosomal SUP35 locus [5]. Standard rich
(YPD) and synthetic (SC) media were used for yeast growth [16].
Transformations with multicopy LEU2 plasmids pRS425-SSA1,
pRS425-SSA1YDJ1, Yeplac181-YDJ1, pFL46-SSB1, pFL46-SSB1YDJ1
and multicopy URA3 plasmid pFL44-HSP104 were performed as
described [17]. pRS425-SSA1 and pRS313-YDJ1 were a kind gift of
S. Lindquist. An Eco72I–Sal I fragment carrying the YDJ1 gene was
isolated from pRS313-YDJ1 and cloned into Yeplac181, pRS425-
SSA1 and pFL46-SSB1. pFL46-SSB1 and pFL44-HSP104 are clones
from the yeast genomic library (M.B., unpublished data). The UAA non-
sense suppression levels were determined by measuring the β-galac-
tosidase activity in cells transformed with pUKC815 and pUKC817
plasmids as described [18]. These plasmids encode a fusion of the 5′
part of the PGK1 gene and the lacZ gene, with a UAA codon inserted
at their junction in pUKC817. 
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